RX Innovations Private Limited
About RX Innovations Private Limited
Data last updated:
RX Innovations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 22 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2021PTC147958.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudheer Kumar Dokuparthi and Suresh Kandagatla.
Its last annual general meeting (AGM) was held on 04 December 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Flat 202 Plot 224 & 225 Road 10 Anupama Nagar Karmanghat, Hyderabad, Telangana, India – 500079.
Company details
Contact details
RX Innovations Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat 202 Plot 224 & 225 Road 10 Anupama Nagar Karmanghat, Hyderabad, Telangana, India – 500079
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of RX Innovations Private Limited
FY 2022 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of RX Innovations Private Limited, buy the company report.
Board of directors of RX Innovations Private Limited
RX Innovations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudheer Kumar Dokuparthi Also directs: Biogenic Products Private Limited | Director | 22 Jan 2021 | 5 Years 9 Months | Current |
| Suresh Kandagatla Also directs: Biogenic Products Private Limited | Director | 22 Jan 2021 | 5 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving RX Innovations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RX Innovations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for RX Innovations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
RX Innovations Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Sudheer Kumar Dokuparthi was appointed as Director on 22 Jan 2021.
Frequently asked questions
RX Innovations is an active private limited company based in Hyderabad, Telangana, India. The company works in science research, within the research and development industry. It was incorporated on 22 January 2021 (5+ years old) and is registered under CIN U73100TG2021PTC147958.
RX Innovations has 2 current directors:
- Sudheer Kumar Dokuparthi - Director
- Suresh Kandagatla - Director
The latest financial statements of RX Innovations on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 04 December 2022. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of RX Innovations is U73100TG2021PTC147958. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RX Innovations was incorporated on 22 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sudheer Kumar Dokuparthi was appointed as Director on 22 Jan 2021. Suresh Kandagatla was appointed as Director on 22 Jan 2021.
The registered office of RX Innovations is at Flat 202 Plot 224 & 225 Road 10 Anupama Nagar Karmanghat, Hyderabad, Telangana, India – 500079.
RX Innovations operates in the research and development industry, in the science research segment.
RX Innovations can be reached at its registered office: Flat 202 Plot 224 & 225 Road 10 Anupama Nagar Karmanghat, Hyderabad, Telangana, India – 500079.
RX Innovations is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
